Lapatinib suppliers

Lapatinib

CAS:: 231277-92-2

MF:: C29H26ClFN4O4S

MW:: 581.06

SecurityInformation

Symbol(GHS) ：: GHS07

Signal word ：: Warning

Hazard statements ：: H319-H362-H413

Precautionary statements ：: P201-P260-P263-P273-P305+P351+P338-P308+P313

WGK Germany ：: WGK 3

HS Code ：: 29349990

Storage Class：: 11 - Combustible Solids

Hazard Classifications：: Aquatic Chronic 4
Eye Irrit. 2
Lact.

Hazardous Substances Data：: 231277-92-2(Hazardous Substances Data)

Use：: Lapatinib, a new member of the 4-anilinoquinazoline class of rtk inhibitors (rtkis), was launched as an oral treatment for breast cancer. lapatinib has dual affinity for egfr and her2 tyrosine kinases. it is indicated in combination with capecitabine for treating patients with advanced or metastatic breast cancer whose tumors overexpress her2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab.

More▼

You can find Lapatinib suppliers, manufacturers, and distributors from countries such as China, United States and the India here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.

SHANDONG BOYUAN PHARMACEUTICAL CO., LTD.